Insider · CIK 0001376548

Ehrich Elliot

Reports to the SEC for 2 companies · CAMBRIDGE, MA

sec.gov

Transactions

Companies

Filings

CIK

0001376548

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2017-05-28	ALKSAlkermes plc. · Restricted Stock Unit AwardM Exercise/Conversion	EVP, R&D & CMO, Alkermes, Inc.	MExercise/Conversion	−3,750 sh	—	—	0
2017-05-28	ALKSAlkermes plc.F Tax Payment	EVP, R&D & CMO, Alkermes, Inc.	FTax Payment	−1,765 sh	$57.70	−$102K	57,056
2017-05-28	ALKSAlkermes plc.M Exercise/Conversion	EVP, R&D & CMO, Alkermes, Inc.	MExercise/Conversion	+3,750 sh	—	—	58,821
2017-04-17	ALKSAlkermes plc.S Sale	EVP, R&D & CMO, Alkermes, Inc.	SSale	−10K sh	$56.60	−$566K	55,071
2017-04-17	ALKSAlkermes plc.M Exercise/Conversion	EVP, R&D & CMO, Alkermes, Inc.	MExercise/Conversion	+10K sh	$16.55	+$166K	65,071
2017-04-17	ALKSAlkermes plc. · Employee Stock Option (Right to Buy)M Exercise/Conversion	EVP, R&D & CMO, Alkermes, Inc.	MExercise/Conversion	−10K sh	—	—	9,801
2017-03-15	ALKSAlkermes plc. · Employee Stock Option (Right to Buy)M Exercise/Conversion	EVP, R&D & CMO, Alkermes, Inc.	MExercise/Conversion	−10K sh	—	—	19,801
2017-03-15	ALKSAlkermes plc.S Sale	EVP, R&D & CMO, Alkermes, Inc.	SSale	−4,100 sh	$56.29	−$231K	61,971
2017-03-15	ALKSAlkermes plc.S Sale	EVP, R&D & CMO, Alkermes, Inc.	SSale	−6,900 sh	$57.00	−$393K	55,071
2017-03-15	ALKSAlkermes plc.M Exercise/Conversion	EVP, R&D & CMO, Alkermes, Inc.	MExercise/Conversion	+10K sh	$16.55	+$166K	66,071
2017-03-03	ALKSAlkermes plc.F Tax Payment	EVP, R&D & CMO, Alkermes, Inc.	FTax Payment	−1,765 sh	$60.97	−$108K	56,071
2017-03-03	ALKSAlkermes plc.M Exercise/Conversion	EVP, R&D & CMO, Alkermes, Inc.	MExercise/Conversion	+3,750 sh	—	—	57,836
2017-03-03	ALKSAlkermes plc. · Restricted Stock Unit AwardM Exercise/Conversion	EVP, R&D & CMO, Alkermes, Inc.	MExercise/Conversion	−3,750 sh	—	—	3,750
2017-03-01	ALKSAlkermes plc.F Tax Payment	EVP, R&D & CMO, Alkermes, Inc.	FTax Payment	−2,706 sh	$59.71	−$162K	54,086
2017-03-01	ALKSAlkermes plc. · Restricted Stock Unit AwardM Exercise/Conversion	EVP, R&D & CMO, Alkermes, Inc.	MExercise/Conversion	−5,750 sh	—	—	17,250
2017-03-01	ALKSAlkermes plc.M Exercise/Conversion	EVP, R&D & CMO, Alkermes, Inc.	MExercise/Conversion	+5,750 sh	—	—	56,792
2017-02-26	ALKSAlkermes plc. · Restricted Stock Unit AwardM Exercise/Conversion	EVP, R&D & CMO, Alkermes, Inc.	MExercise/Conversion	−3,750 sh	—	—	7,500
2017-02-26	ALKSAlkermes plc.F Tax Payment	EVP, R&D & CMO, Alkermes, Inc.	FTax Payment	−1,765 sh	$52.98	−$93.5K	51,042
2017-02-26	ALKSAlkermes plc.M Exercise/Conversion	EVP, R&D & CMO, Alkermes, Inc.	MExercise/Conversion	+3,750 sh	—	—	52,807
2017-02-21	ALKSAlkermes plc.G Gift	EVP, R&D & CMO, Alkermes, Inc.	GGift	−600 sh	—	—	49,057
2017-02-17	ALKSAlkermes plc. · Restricted Stock Unit AwardA Award	EVP, R&D & CMO, Alkermes, Inc.	AAward	+15K sh	—	—	15,000
2017-02-17	ALKSAlkermes plc. · Employee Stock Option (Right to Buy)A Award	EVP, R&D & CMO, Alkermes, Inc.	AAward	+65K sh	—	—	65,000
2017-02-16	ALKSAlkermes plc.M Exercise/Conversion	EVP, R&D & CMO, Alkermes, Inc.	MExercise/Conversion	+10K sh	$16.55	+$166K	59,657
2017-02-16	ALKSAlkermes plc.S Sale	EVP, R&D & CMO, Alkermes, Inc.	SSale	−6,085 sh	$56.84	−$346K	49,657
2017-02-16	ALKSAlkermes plc.S Sale	EVP, R&D & CMO, Alkermes, Inc.	SSale	−3,915 sh	$56.05	−$219K	55,742
2017-02-16	ALKSAlkermes plc. · Employee Stock Option (Right to Buy)M Exercise/Conversion	EVP, R&D & CMO, Alkermes, Inc.	MExercise/Conversion	−10K sh	—	—	29,801
2017-02-15	ALKSAlkermes plc.S Sale	EVP, R&D & CMO, Alkermes, Inc.	SSale	−1,000 sh	$58.17	−$58.2K	49,657
2017-01-17	ALKSAlkermes plc.S Sale	EVP, R&D & CMO, Alkermes, Inc.	SSale	−12K sh	$54.32	−$651K	50,657
2017-01-17	ALKSAlkermes plc.M Exercise/Conversion	EVP, R&D & CMO, Alkermes, Inc.	MExercise/Conversion	+10K sh	$16.55	+$166K	62,640
2017-01-17	ALKSAlkermes plc. · Employee Stock Option (Right to Buy)M Exercise/Conversion	EVP, R&D & CMO, Alkermes, Inc.	MExercise/Conversion	−10K sh	—	—	39,801
2017-01-06	ALKSAlkermes plc. · Employee Stock Option (Right to Buy)M Exercise/Conversion	EVP, R&D & CMO, Alkermes, Inc.	MExercise/Conversion	−2,100 sh	—	—	6,000
2017-01-06	ALKSAlkermes plc.S Sale	EVP, R&D & CMO, Alkermes, Inc.	SSale	−2,100 sh	$60.12	−$126K	52,640
2017-01-06	ALKSAlkermes plc.M Exercise/Conversion	EVP, R&D & CMO, Alkermes, Inc.	MExercise/Conversion	+2,100 sh	$18.11	+$38K	54,740
2017-01-05	ALKSAlkermes plc.M Exercise/Conversion	EVP, R&D & CMO, Alkermes, Inc.	MExercise/Conversion	+400 sh	$18.11	+$7,242	53,040
2017-01-05	ALKSAlkermes plc. · Employee Stock Option (Right to Buy)M Exercise/Conversion	EVP, R&D & CMO, Alkermes, Inc.	MExercise/Conversion	−400 sh	—	—	8,100
2017-01-05	ALKSAlkermes plc.S Sale	EVP, R&D & CMO, Alkermes, Inc.	SSale	−400 sh	$60.08	−$24K	52,640
2017-01-04	ALKSAlkermes plc.S Sale	EVP, R&D & CMO, Alkermes, Inc.	SSale	−5,000 sh	$58.83	−$294K	55,140
2017-01-04	ALKSAlkermes plc.S Sale	EVP, R&D & CMO, Alkermes, Inc.	SSale	−2,500 sh	$60.01	−$150K	52,640
2017-01-04	ALKSAlkermes plc.M Exercise/Conversion	EVP, R&D & CMO, Alkermes, Inc.	MExercise/Conversion	+7,500 sh	$18.11	+$136K	60,140
2017-01-04	ALKSAlkermes plc. · Employee Stock Option (Right to Buy)M Exercise/Conversion	EVP, R&D & CMO, Alkermes, Inc.	MExercise/Conversion	−7,500 sh	—	—	8,500
2016-12-15	ALKSAlkermes plc.S Sale	EVP, R&D & CMO, Alkermes, Inc.	SSale	−5,000 sh	$55.99	−$280K	52,640
2016-12-15	ALKSAlkermes plc.M Exercise/Conversion	EVP, R&D & CMO, Alkermes, Inc.	MExercise/Conversion	+5,000 sh	$18.11	+$90.5K	57,640
2016-12-15	ALKSAlkermes plc. · Employee Stock Option (Right to Buy)M Exercise/Conversion	EVP, R&D & CMO, Alkermes, Inc.	MExercise/Conversion	−5,000 sh	—	—	16,000
2016-12-12	ALKSAlkermes plc.S Sale	EVP, R&D & CMO, Alkermes, Inc.	SSale	−17K sh	$55.15	−$937K	52,640
2016-12-12	ALKSAlkermes plc. · Employee Stock Option (Right to Buy)M Exercise/Conversion	EVP, R&D & CMO, Alkermes, Inc.	MExercise/Conversion	−5,000 sh	—	—	21,000
2016-12-12	ALKSAlkermes plc.M Exercise/Conversion	EVP, R&D & CMO, Alkermes, Inc.	MExercise/Conversion	+10K sh	$16.55	+$166K	64,623
2016-12-12	ALKSAlkermes plc.M Exercise/Conversion	EVP, R&D & CMO, Alkermes, Inc.	MExercise/Conversion	+5,000 sh	$18.11	+$90.5K	69,623
2016-12-12	ALKSAlkermes plc. · Employee Stock Option (Right to Buy)M Exercise/Conversion	EVP, R&D & CMO, Alkermes, Inc.	MExercise/Conversion	−10K sh	—	—	49,801
2016-11-07	ALKSAlkermes plc.F Tax Payment	EVP, R&D & CMO, Alkermes, Inc.	FTax Payment	−1,852 sh	$53.97	−$100K	54,623
2016-11-07	ALKSAlkermes plc.M Exercise/Conversion	EVP, R&D & CMO, Alkermes, Inc.	MExercise/Conversion	+8,517 sh	$11.74	+$100K	56,475

Recent filings

Accepted (ET)
May 304
Alkermes plc.0001127602-17-019705
SEC(opens sec.gov)
Apr 184
Alkermes plc.0001127602-17-014942
SEC(opens sec.gov)
Mar 164
Alkermes plc.0001127602-17-011997
SEC(opens sec.gov)
Mar 64
Alkermes plc.0001127602-17-010466
SEC(opens sec.gov)
Mar 24
Alkermes plc.0001127602-17-009853
SEC(opens sec.gov)
Feb 274
Alkermes plc.0001127602-17-008683
SEC(opens sec.gov)
Feb 214
Alkermes plc.0001127602-17-007489
SEC(opens sec.gov)

Companies

Address

88 SIDNEY STREET

CAMBRIDGE, MA, 02139